Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 3 (A) Representative immunoblots showing transforming growth factor (TGF)-ß1 protein level in the infarcted and non-infarcted sites on days 3 and 14 among sham-operated rats (Sham), Sham treated with romurtide (Sham/Ro), myocardial infarction rats treated with saline (MI/C), and MI treated with romurtide (MI/Ro). (B) Quantified data of TGF-ß1 protein expression in the infarcted and non-infarcted sites among Sham, Sham/Ro, MI/C, and MI/Ro (n = 4 per group). Values are mean ± SEM. *p < 0.05 versus Sham; {dagger}p < 0.05 versus Sham/Ro; {ddagger}p < 0.05 versus MI/C.





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement